Merck Serono
Latest Press Release
MERCK SERONO HAS INITIATED THE ONWARD STUDY TO EVALUATE ORAL CLADRIBINE AS ADD-ON TREATMENT FOR MULTIPLE SCLEROSIS
ONWARD Phase II ... more »
|
|||
|
Multiple Sclerosis Information
Search
This Month
Favorite Links
Month Archive
|
Saturday, February 3
by
All About MS
on Sat 03 Feb 2007 12:00 AM CST
by
All About MS
on Sat 03 Feb 2007 12:00 AM CST
|
||